MedPath

Study on the Level of Neuromuscular Blockade

Not Applicable
Completed
Conditions
Neuromuscular Blockade
Interventions
Drug: A continuous intravenous infusion of 0.2-0.3 mg/kg/h Rocuronium Bromide Intravenous Solution (50 Mg/5 mL) to keep the target neuromuscular blockade (TOF = 1-2).
Drug: A continuous intravenous infusion of 0.5-0.6 mg/kg/h Rocuronium Bromide Intravenous Solution (50 Mg/5 mL) to keep the target neuromuscular blockade (PTC = 1-2).
Registration Number
NCT03782233
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Brief Summary

On the basis of moderate pneumoperitoneum pressure(10 mmHg), this study evaluates the effect of different level of neuromuscular blockade to gastrointestinal barrier function during laparoscopic gastrectomy. 83 patients are randomized to 2 arms ,The patients in deep neuromuscular blockade group(group D, PTC=1-2)will receive high dose rocuronium (0.5-0.6 mg/kg/h) ;While the patients in moderate neuromuscular blockade group(group M, TOF=1-2)will receive moderate dose rocuronium (0.2-0.3 mg/kg/h)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
83
Inclusion Criteria
  1. Age:40-80;
  2. BMI < 30kg/m2;
  3. ASA classification:Ⅰ-Ⅲ;
  4. Undergoing elective laparoscopic gastrectomy.
Exclusion Criteria
  1. Preoperative history of inflammatory intestinal diseases, intestinal flora disorders, obstructive jaundice, intestinal obstruction, irritable bowel syndrome and other digestive diseases;
  2. Severe heart, lung, liver, kidney, brain and other diseases;
  3. Serious infection, pancreatitis, burns, trauma, need a large dose, long-term use of antibiotics before the operation;
  4. A history of abdominal surgery;
  5. Combined with gravis myasthenia, serious electrolyte disorders or neuromuscular diseases.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
moderate neuromuscular blockade group (Group M)A continuous intravenous infusion of 0.2-0.3 mg/kg/h Rocuronium Bromide Intravenous Solution (50 Mg/5 mL) to keep the target neuromuscular blockade (TOF = 1-2).Patients undergoing elective laparoscopic surgery for gastrectomy will be randomized to receive moderate neuromuscular blockade (train-of-four count = 1-2) using moderate dose rocuronium.
deep neuromuscular blockade group (Group D)A continuous intravenous infusion of 0.5-0.6 mg/kg/h Rocuronium Bromide Intravenous Solution (50 Mg/5 mL) to keep the target neuromuscular blockade (PTC = 1-2).Patients undergoing elective laparoscopic surgery for gastrectomy will be randomized to receive deep neuromuscular blockade (post-tetanic count = 1-2) using high dose rocuronium.
Primary Outcome Measures
NameTimeMethod
Plasma Concentration of Diamine Oxidase (DAO) 24 h After the Surgery24 h after the Surgery

The level of DAO can indicate the damage to the gastrointestinal barrier .

Plasma Concentration of D-lactic Acid Before the Surgery1 day before the surgery

The level of D-lactic acid can indicate the damage to the gastrointestinal barrier .

Plasma Concentration of Diamine Oxidase (DAO) Before the Surgery1 day Before the Surgery

The level of DAO can indicate the damage to the gastrointestinal barrier .

Total Number of Operational Taxonomic Units (OUTs) of Intestinal Microbiotathe first time of defecation after operation

Intestinal microbiota was analyzed by 16S rRNA sequencing. To be specific, first, DNA was extracted and quantified. Bacterial 16S rRNA genes of the V3-V4 region were amplified from extracted DNA using the barcoded primers (5'- CCTACGGRRBGCASCAGKVRVGAAT-3') and (5'- GGACTACNVGGGTWTCTAATCC-3'). PCR reactions were performed and the PCR mixture applied to the PCR amplifier. Then, the PCR products were checked for size and specificity by agarose gel electrophoresis and purified. Finally, high-throughput sequencing was performed using the Illumina MiSeq platform.

The raw reads were filtered to remove low quality sequences and the filtered data were further merged into tags by FLASH(Version 1.2.7). Then the Uchime algorithm in Usearch software was applied to remove chimeric tags. Resulting tags for each sample were clustered into operational taxonomic units(OTUs) at the level of 97% similarity.

Higher values represent a more abundant amount of bacteria in gut.

Postoperative Exhaust TimeIt is calculated from the end of the operation to the time of exhaust.

It's a regular measurement to evaluate the function of gastrointestinal tract . It is calculated from the end of the operation to the time of exhaust.

Plasma Concentration of D-lactic Acid 24 h After the Surgery24 h after the surgery

The level of D-lactic acid can indicate the damage to the gastrointestinal barrier .

16s rRNA Sequencing of Postoperative Fecesthe first time of defecation after operation

Alpha and Beta diversity; relative abundance of gut microbiota. Alpha diversity includes Chao 1 index, Shannon index, and Simpson index. A higher value of Chao 1 index corresponds to more abundant number of microbiota. A higher value of Shannon index corresponds to more abundance. And A higher value of Simpson index corresponds to less diversity.

Bata diversity was assessed by PCoA analysis. A three dimensional scatter plot was presented to visualize the similarities and differences between the two groups.

Relative Abundance of Intestinal Microbiotathe first time of defecation after operation

Intestinal microbiota is one of the factors related to the recovery of intestinal function. It can be analyzed by 16S rRNA sequencing of the postoperative feces.

Secondary Outcome Measures
NameTimeMethod
Postoperative VAS (12 h After Surgery, Rest State)12 h after surgery

VAS pain score: 0 - completely painless, 10 - unbearable pain.

Postoperative VAS (12 h After Surgery, Active State)12 h after surgery

VAS pain score: 0 - completely painless, 10 - unbearable pain.

Postoperative VAS (24 h After Surgery, Rest State)24 h after surgery

VAS pain score: 0 - completely painless, 10 - unbearable pain.

Duration of SurgeryFrom the first dose of anesthetic to the end of the surgery

Time from the first dose of anesthetic to the end of the surgery

Surgical Condition Scores Rated by SurgeonsDuring operation, within 2 hours

evaluation of the surgical condition by 5 point scale: 5 points: optimal; 4 points: good; 3 points: acceptable; 2 points: poor; 1 point: extremely poor.

Duration of CO2 Pneumoperitoneumfrom the beginning to the end of CO2 pneumoperitoneum

Time from the beginning to the end of CO2 pneumoperitoneum

Duration of Postoperative Hospital Stayfrom the end of surgery to the time of being discharged from hospital

Duration from the day of surgery to the day the patient discharged from the hospital

Postoperative VAS (24 h After Surgery, Active State)24 h after surgery

VAS pain score: 0 - completely painless, 10 - unbearable pain.

Surgical Condition Scores Rated by Surgeons (Average Scores)during surgery

evaluation of the surgical condition by 5 point scale: 5 points: optimal; 4 points: good; 3 points: acceptable; 2 points: poor; 1 point: extremely poor.

Postoperative VAS (48 h After Surgery, Rest State)48 h after surgery

VAS pain score: 0 - completely painless, 10 - unbearable pain.

Postoperative VAS (48 h After Surgery, Active State)48 h after surgery

VAS pain score: 0 - completely painless, 10 - unbearable pain.

Trial Locations

Locations (1)

The First Affiliated Hospital with Nanjing Medical University

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath